Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 26, 2021

SELL
$78.0 - $104.5 $149,916 - $200,849
-1,922 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$95.51 - $112.95 $24,164 - $28,576
253 Added 15.16%
1,922 $198,000
Q2 2020

Jul 07, 2020

BUY
$62.68 - $105.34 $104,612 - $175,812
1,669 New
1,669 $677,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Paragon Advisors, LLC Portfolio

Follow Paragon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Advisors, LLC with notifications on news.